Adaptive Biotechnologies Corporation (ADPT) Profit Margins
Over the twelve months to 2026-06-30, Adaptive Biotechnologies Corporation (ADPT) had gross margin 75.6%, operating margin -12.2%, net margin -20.7%, free cash flow margin -7.8%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ADPTAdaptive Biotechnologies CorporationFollow ADPT — free
—
Price chart with a free account
- Market cap
- 4.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 73.8% | 77.1% | 68.1% | 68.7% | 55.6% | 59.7% | 74.2% | 75.6% | |
| Operating margin | -92.1% | -155.3% | -135.4% | -108.0% | -133.3% | -90.8% | -20.6% | -12.2% | |
| Net margin | -80.6% | -148.6% | -134.3% | -108.0% | -132.3% | -89.1% | -21.5% | -20.7% | |
| FCF margin | 228.3% | -171.3% | -164.9% | -108.1% | -98.1% | -55.3% | -17.7% | -7.8% |
USD billions · SEC XBRL
Adaptive Biotechnologies Corporation — questions
- What is Adaptive Biotechnologies Corporation's gross margin?
- 75.6% over the twelve months to 2026-06-30.
- What is Adaptive Biotechnologies Corporation's operating margin?
- -12.2% over the twelve months to 2026-06-30.
- What is Adaptive Biotechnologies Corporation's net profit margin?
- -20.7% over the twelve months to 2026-06-30.
Every figure on this page comes from Adaptive Biotechnologies Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.